Invention Grant
- Patent Title: Pyridin-2-one derivatives of formula (I) useful as EP3 receptor antagonists
-
Application No.: US16059072Application Date: 2018-08-09
-
Publication No.: US10590083B2Publication Date: 2020-03-17
- Inventor: Xuqing Zhang , Mark J. Macielag
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Main IPC: C07D213/64
- IPC: C07D213/64 ; C07D401/14 ; A61P3/10 ; C07D413/14 ; C07D413/06
Abstract:
The present invention is directed to pyridin-2-one derivatives, pharmaceutical compositions containing them and their use as antagonists of the EP3 receptor, for the treatment of for example, impaired oral glucose tolerance, elevated fasting glucose, Type II Diabetes Mellitus, Syndrome X (also known as Metabolic Syndrome) and related disorders and complications thereof.
Public/Granted literature
- US20190047959A1 PYRIDIN-2-ONE DERIVATIVES OF FORMULA (I) USEFUL AS EP3 RECEPTOR ANTAGONISTS Public/Granted day:2019-02-14
Information query
IPC分类:
